<DOC>
	<DOCNO>NCT00127647</DOCNO>
	<brief_summary>The purpose trial evaluate efficacy safety investigational drug adult patient allergic rhinitis .</brief_summary>
	<brief_title>An Approved Drug Study New Indication Allergic Rhinitis ( 0476-327 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Pranlukast</mesh_term>
	<criteria>Japanese male females 2year documented history seasonal allergic rhinitis symptom positive allergy testing ( cedar , alder and/or cypress ) Patients druginduced rhinitis nonallergic rhinitis , patient use antihistamine drug ( within 2 week ) start observation period</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>